The PE Ratio as of May 2025 (TTM) for UCB SA (UCBJY) is 29.03

According to UCB SA’s latest financial reports and current stock price. The company's current PE Ratio is 29.03. This represents a change of -32.65% compared to the average of 43.10 of the last 4 quarters.

UCB SA (UCBJY) Historical PE Ratio (quarterly & annually)

How has UCBJY PE Ratio performed in the past?

The mean historical PE Ratio of UCB SA over the last ten years is 28.41. The current 29.03 PE Ratio has changed 10.12% with respect to the historical average. Over the past ten years (40 quarters), UCBJY's PE Ratio was at its highest in in the December 2022 quarter at 183.51. The PE Ratio was at its lowest in in the June 2008 quarter at -165.03.

UCB SA (UCBJY) PE Ratio by Quarter and Year

Discovering the peaks and valleys of UCB SA PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

UCB SA (UCBJY) Average PE Ratio

How has UCBJY PE Ratio performed in the past?

The current PE Ratio of UCB SA (UCBJY) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

UCB SA (UCBJY) PE Ratio vs. Peers

How is UCBJY’s PE Ratio compared to its peers?

UCB SA’s PE Ratio is greater than Comera Life Sciences Holdings, Inc. (-0.00), greater than AnPac Bio-Medical Science Co., Ltd. (-0.57), greater than Novan, Inc. (-0.11), greater than Tonix Pharmaceuticals Holding Corp. (-1.44), greater than NextCure, Inc. (-0.25), greater than CytomX Therapeutics, Inc. (4.25), greater than Neoleukin Therapeutics, Inc. (-0.67), greater than Spero Therapeutics, Inc. (-0.64), greater than Assembly Biosciences, Inc. (-2.52), greater than Galmed Pharmaceuticals Ltd. (-0.26), less than Affimed N.V. (0), greater than Abeona Therapeutics Inc. (-0.06), greater than Akebia Therapeutics, Inc. (-6.87), greater than iTeos Therapeutics, Inc. (-13.56), less than Icosavax, Inc. (0), greater than Mirati Therapeutics, Inc. (-2.58), greater than VectivBio Holding AG (-15.78), greater than Annexon, Inc. (-11.26), greater than null (-7.94), greater than null (-1.78),

Build a custom stock screener for UCB SA (UCBJY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like UCB SA using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

UCB SA (UCBJY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like UCB SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.